Perivascular Inflammation and Vascular Remodeling: A Common Cause of Hemorrhage in Cerebral Small Vessel Diseases?
血管周围炎症和血管重塑:脑小血管疾病出血的常见原因?
基本信息
- 批准号:10861499
- 负责人:
- 金额:$ 77.65万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-08-01 至 2024-07-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Project Summary / Abstract
Title project: “Perivascular inflammation and vascular remodeling: a common cause of hemorrhage in cerebral
small vessel diseases?”
Cerebral small vessel disease (CSVD) is a major contributor to intracerebral hemorrhage in the aging human
brain. The two most common sporadic forms of CSVD are cerebral amyloid angiopathy (CAA) and
arteriolosclerosis. By the time CSVD is diagnosed during life, the underlying small vessel pathology has
already advanced to end-stage disease. There are currently no treatments that target the final steps leading up
to vessel rupture and hemorrhage. This proposal builds on recent key observations from the applicant’s lab
suggesting immune-mediated vascular remodeling and reduced β-amyloid in individual vessels associated with
microhemorrhages in CAA. This project will test the overarching hypothesis that perivascular inflammation
contributes to vascular remodeling, resulting in vessel rupture and hemorrhage in CAA. Understanding these
fundamental pathophysiological mechanisms may uncover novel targets for much needed treatment strategies.
This project will leverage well-characterized autopsy cases of patients with a neuropathologically confirmed
diagnosis of CAA and other forms of sporadic and hereditary CSVD to determine shared pathways. The
complementary use of quantitative neuropathology in human brain tissue samples with longitudinal in vivo two-
photon microscopy in mouse models with CAA will allow studying the sequence of events leading up to vessel
wall remodeling and hemorrhage in real-time. If successful, the outcomes of this project are expected to have
high impact, because 1) the analyses are targeted at the disease stage present at the time CSVD is
diagnosed, 2) inflammatory pathways have substantial likelihood to be ‘druggable’ (i.e. response to candidate
intervention), and 3) since arteriolosclerosis also seems to entail a gradual loss of normal vessel wall
components followed by remodeling and vessel rupture, there is high potential for the results of the CAA study
to generalize to the other common CSVD.
项目摘要 /摘要
标题项目:“血管周围注射和血管重塑:大脑出血的常见原因
小血管疾病?”
脑小血管疾病(CSVD)是衰老人衰老的脑内出血的主要因素
脑。 CSVD的两种最常见的形式是脑淀粉样血管病(CAA)和
动脉粥样硬化。到CSVD在生命中被诊断出来时,潜在的小血管病理已经
已经患上了终点疾病。目前尚无针对最终步骤的治疗方法
船舶破裂和出血。该提案以申请人实验室的最新关键观察为基础
提示免疫介导的血管重塑,并减少与
CAA中的微视角。该项目将测试周围注射的总体假设
导致血管重塑,导致CAA的血管破裂和出血。了解这些
基本的病理生理机制可能会发现急需治疗策略的新目标。
该项目将利用神经病理学确认的患者的训练术病例
诊断CAA和其他形式的零星和遗传性CSVD,以确定共享途径。这
在人类脑组织样品中完全使用定量神经病理学
具有CAA的小鼠模型中的光子显微镜将允许研究导致血管的事件序列
实时重塑和出血。如果成功,则预计该项目的结果将有
高影响力,因为1)分析是针对CSVD当时存在的疾病阶段
被诊断为2)炎症途径很有可能是“可药的”(即对候选人的反应
干预)和3),因为动脉硬化似乎也导致正常血管壁的损失
组件随后进行了重塑和血管破裂,CAA研究的结果很高
概括到其他常见的CSVD。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据
数据更新时间:2024-06-01
Susanne Janneke Va...的其他基金
Mechanisms of vasomotion-mediated perivascular clearance in cerebral amyloid angiopathy
脑淀粉样血管病血管舒缩介导的血管周围清除机制
- 批准号:1051890910518909
- 财政年份:2022
- 资助金额:$ 77.65万$ 77.65万
- 项目类别:
Mechanisms of Vasomotion-mediated Perivascular Clearance in Cerebral Amyloid Angiopathy
脑淀粉样血管病中血管舒缩介导的血管周围清除机制
- 批准号:1066978610669786
- 财政年份:2022
- 资助金额:$ 77.65万$ 77.65万
- 项目类别:
Unraveling the mechanisms of microhemorrhages in cerebral amyloid angiopathy
揭示脑淀粉样血管病微出血的机制
- 批准号:1040638210406382
- 财政年份:2018
- 资助金额:$ 77.65万$ 77.65万
- 项目类别:
相似国自然基金
温度作用下CA砂浆非线性老化蠕变性能的多尺度研究
- 批准号:12302265
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于波动法的叠层橡胶隔震支座老化损伤原位检测及精确评估方法研究
- 批准号:52308322
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
微纳核壳结构填充体系构建及其对聚乳酸阻燃、抗老化、降解和循环的作用机制
- 批准号:52373051
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
东北黑土中农膜源微塑料冻融老化特征及其毒性效应
- 批准号:42377282
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
高层建筑外墙保温材料环境暴露自然老化后飞火点燃机理及模型研究
- 批准号:52376132
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
相似海外基金
Measuring the Impact of the Value Flower and Unobserved Heterogeneity on the Cost Effectiveness and Use of Novel Treatments for Alzheimer's Disease and Related Dementias
衡量价值花和未观察到的异质性对阿尔茨海默病和相关痴呆症新疗法的成本效益和使用的影响
- 批准号:1065845710658457
- 财政年份:2023
- 资助金额:$ 77.65万$ 77.65万
- 项目类别:
A 5-HTergic DRN vCA1 circuit and Alzheimer's disease
5-HTergic DRN vCA1 回路与阿尔茨海默病
- 批准号:1074005010740050
- 财政年份:2023
- 资助金额:$ 77.65万$ 77.65万
- 项目类别:
Inhibition of Complement Pathways with VCP As A Treatment For Alzheimer's Disease
VCP 抑制补体途径治疗阿尔茨海默病
- 批准号:1060275710602757
- 财政年份:2023
- 资助金额:$ 77.65万$ 77.65万
- 项目类别:
Advancing Geriatrics Infrastructure and Network Growth (AGING) Initiative
推进老年病学基础设施和网络发展 (AGING) 计划
- 批准号:1073229110732291
- 财政年份:2023
- 资助金额:$ 77.65万$ 77.65万
- 项目类别:
Innovative precision medicine methods in subgroup identification for Alzheimer's disease
阿尔茨海默病亚组鉴定的创新精准医学方法
- 批准号:1074064910740649
- 财政年份:2023
- 资助金额:$ 77.65万$ 77.65万
- 项目类别: